According to a recently published report by Roots Analysis, the growing prevalence of chronic diseases, the surge in patient preference for oral therapeutic drugs, and improved patient compliance are anticipated to drive the market. LONDON, Jan. 17, 2024 /PRNewswire/ — Global Oral…